Impact of Inappropriate Empiric Treatment of Acinetobacter Baumannii Pneumonia and Sepsis on Hospital Mortality

Chest - United States
doi 10.1016/j.chest.2016.08.123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immunization Against Multidrug-Resistant Acinetobacter Baumannii Effectively Protects Mice in Both Pneumonia and Sepsis Models

PLoS ONE
Multidisciplinary
2014English

Incidence and Predictors of 14-Day Mortality in Multidrug-Resistant Acinetobacter Baumannii in Ventilator-Associated Pneumonia

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2015English

Impact of Macrolide Therapy on Mortality in Severe Sepsis Caused by Pneumonia

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2009English

Colistin Plus Carbapenem Versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Pneumonia

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality After Pneumonia and Sepsis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2008English

Endemic Acinetobacter Baumannii in a New York Hospital

PLoS ONE
Multidisciplinary
2011English

High-Dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter Baumannii

The Korean Journal of Critical Care Medicine
2016English

Biological Sex Influences Susceptibility to Acinetobacter Baumannii Pneumonia in Mice

JCI insight
Medicine
2020English

Antibody Dependent Enhancement of Acinetobacter Baumannii Infection in a Mouse Pneumonia Model

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy